232 related articles for article (PubMed ID: 32196610)
1. LncRNA MALAT1 knockdown inhibits cell migration and invasion by suppressing autophagy through miR-384/GOLM1 axis in glioma.
Ma R; Zhang BW; Zhang ZB; Deng QJ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2601-2615. PubMed ID: 32196610
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
Song J; Su ZZ; Shen QM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
[TBL] [Abstract][Full Text] [Related]
3. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a.
Zhao ZB; Chen F; Bai XF
Yonsei Med J; 2019 Aug; 60(8):727-734. PubMed ID: 31347327
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MALAT1 regulates trophoblast cells migration and invasion via miR-206/IGF-1 axis.
Wu HY; Wang XH; Liu K; Zhang JL
Cell Cycle; 2020 Jan; 19(1):39-52. PubMed ID: 31774373
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101.
Li Z; Xu C; Ding B; Gao M; Wei X; Ji N
J Neurooncol; 2017 Aug; 134(1):19-28. PubMed ID: 28551849
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
Suo ST; Gong P; Peng XJ; Niu D; Guo YT
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
[TBL] [Abstract][Full Text] [Related]
8. The knockdown of MALAT1 inhibits the proliferation, invasion and migration of hemangioma endothelial cells by regulating MiR-206 / VEGFA axis.
Wang S; Ren L; Shen G; Liu M; Luo J
Mol Cell Probes; 2020 Jun; 51():101540. PubMed ID: 32084582
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer.
Xu F; Hu Y; Gao J; Wang J; Xie Y; Sun F; Wang L; Miyamoto A; Xia O; Zhang C
Curr Cancer Drug Targets; 2023; 23(5):363-378. PubMed ID: 36579395
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis.
Liu N; Feng S; Li H; Chen X; Bai S; Liu Y
J Cancer Res Clin Oncol; 2020 Feb; 146(2):367-379. PubMed ID: 31953613
[TBL] [Abstract][Full Text] [Related]
13. Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma.
Fu Z; Luo W; Wang J; Peng T; Sun G; Shi J; Li Z; Zhang B
Biochem Biophys Res Commun; 2017 Oct; 492(3):480-486. PubMed ID: 28834690
[TBL] [Abstract][Full Text] [Related]
14. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
[No Abstract] [Full Text] [Related]
16. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway.
Li MM; Dong CX; Sun B; Lei HZ; Wang YL; Gong YB; Sun LL; Sun ZW
Life Sci; 2019 Dec; 239():116946. PubMed ID: 31610202
[TBL] [Abstract][Full Text] [Related]
17. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
18. Down-Regulation of Lncrna MALAT1 Attenuates Neuronal Cell Death Through Suppressing Beclin1-Dependent Autophagy by Regulating Mir-30a in Cerebral Ischemic Stroke.
Guo D; Ma J; Yan L; Li T; Li Z; Han X; Shui S
Cell Physiol Biochem; 2017; 43(1):182-194. PubMed ID: 28854438
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 promotes glioma cell growth through sponge miR-613.
Su Y; Liang C; Yang Q
J BUON; 2021; 26(3):984-991. PubMed ID: 34268963
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of XIST facilitates cell proliferation, invasion and suppresses cell apoptosis by reducing radio-sensitivity of glioma cells via miR-329-3p/CREB1 axis.
Wang YP; Li HQ; Chen JX; Kong FG; Mo ZH; Wang JZ; Huang KM; Li XN; Yan Y
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3190-3203. PubMed ID: 32271437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]